AstraZeneca may have used outdated info in vaccine trial: U.S.
AstraZeneca reported on Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study
Full Article
AstraZeneca may have used outdated info in vaccine trial: U.S.
Hindu
0 shares
3 views
You might like
Related news coverage
Doctor on new AstraZeneca vaccine data, media coverage of pandemic
CBS News
After U.S. health officials called out AstraZeneca for using "outdated information" in its vaccine trial results, the drugmaker has..
-
AstraZeneca revises down its vaccine efficacy in a huge US trial, from 79% to 76%, following concerns from Fauci and other experts that the results were outdated
Business Insider
-
Coronavirus digest: AstraZeneca corrects 'outdated' trial results
Deutsche Welle
-
AstraZeneca says COVID-19 vaccine shows 76% efficacy in updated analysis of U.S. trial
CBC.ca
-
AstraZeneca may have provided "outdated" coronavirus vaccine data, safety board claims
NaturalNews.com
Advertisement
More coverage
AstraZeneca says its vaccine shows 76 percent efficacy after questions arise about 'outdated information'
Upworthy
The company had faced questions about outdated information but said Wednesday that the analysis of a U.S. trial confirms it is safe..
-
AstraZeneca presented US with OUTDATED and CHERRY-PICKED vaccine trial data, concludes independent monitoring board
NaturalNews.com
-
Spaniards line up for AstraZeneca amid concerns over vaccine
SeattlePI.com
-
Spaniards line up for AstraZeneca amid concerns over vaccine
SeattlePI.com
-
AstraZeneca accused of cherry-picking vaccine study data. U.S. health officials say results from a trial of AstraZeneca’s COVID-19...
Upworthy